Marilena Vrana: Advancing Early Diagnosis and Access to Plasma Medicines for World PI Week 2026
Marilena Vrana, Vice President at the Plasma Protein Therapeutics Association (PPTA) Europe, shared a post on LinkedIn:
“World PI Week 2026 is here.
Working in the plasma community, I am continually inspired by the strength and resilience of the people living with Primary Immunodeficiency that I have met from around the world.
This week is an important opportunity to raise awareness, amplify patient voices, and highlight the critical importance of early diagnosis and access to care. I’m proud to stand alongside patients, advocates, and partners who are driving progress every day.
Together, we must continue working toward a future where all patients have access to the support and treatments they need, including life-saving plasma–derived medicines.”
Find more posts featuring Marilena Vrana on Hemostasis Today.
-
Aug 13, 2026, 18:39Lukas Röthlisberger: Real-World Evidence on Effectiveness and Safety of Rivaroxaban in Children
-
Aug 13, 2026, 18:36Soner Yilmaz: Blood Safety in Türkiye Through More Than 22.5 Million Blood Donations
-
Aug 13, 2026, 18:31Muthukumarasamy Raja: FDA Approval of EZPLAZ Marks a Breakthrough in Emergency Plasma Care
-
Aug 13, 2026, 18:29Peter Zdziarski: Protecting Our Community While Creating a Future Where We Are No Longer Needed
-
Aug 13, 2026, 18:29Morgan E Amos: Thrilled to Receive the Student Research Award From HTRS
-
Aug 13, 2026, 16:38Sheharyar Raza: Plasma Exchange in Multiple Sclerosis
-
Aug 13, 2026, 16:31Juan Manuel Cisneros Carrasco: The True Cost of Blood Donation
-
Aug 13, 2026, 16:25Connie Montgomery: Bridging the Gap Between Patients, Culture and Clinical Trials
-
Aug 13, 2026, 16:16Isabella Presch: A New AI Approach to Protein Engineering